Menu
GeneBe

TUBA1A

tubulin alpha 1a, the group of Tubulins

Basic information

Region (hg38): 12:49184685-49189080

Links

ENSG00000167552NCBI:7846OMIM:602529HGNC:20766Uniprot:Q71U36AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • intellectual disability, autosomal dominant 40 (Definitive), mode of inheritance: AD
  • lissencephaly due to TUBA1A mutation (Definitive), mode of inheritance: AD
  • lissencephaly due to TUBA1A mutation (Strong), mode of inheritance: AD
  • lissencephaly due to TUBA1A mutation (Supportive), mode of inheritance: AD
  • tubulinopathy-associated dysgyria (Supportive), mode of inheritance: AD
  • lissencephaly due to TUBA1A mutation (Strong), mode of inheritance: AD
  • lissencephaly due to TUBA1A mutation (Strong), mode of inheritance: AD
  • tubulinopathy (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Lissencephaly 3ADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic17218254; 17584854; 18728072; 18954413; 21403111; 22264709; 22633752; 22948023; 23317684; 23528852; 23361065

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TUBA1A gene.

  • not provided (180 variants)
  • Tubulinopathy (113 variants)
  • Lissencephaly due to TUBA1A mutation (93 variants)
  • not specified (34 variants)
  • Inborn genetic diseases (21 variants)
  • Tubulinopathy-associated dysgyria (7 variants)
  • TUBA1A-related condition (6 variants)
  • Lissencephaly (5 variants)
  • TUBA1A-associated tubulinopathy (4 variants)
  • Lissencephaly type 3 (3 variants)
  • Cerebral palsy (2 variants)
  • Congenital fibrosis of extraocular muscles;Congenital bilateral perisylvian syndrome (2 variants)
  • Abnormal brainstem morphology;Abnormal cortical gyration (1 variants)
  • Abnormal cerebral morphology (1 variants)
  • Abnormality of neuronal migration (1 variants)
  • Neurodevelopmental disorder (1 variants)
  • Lissencephaly;Polymicrogyria (1 variants)
  • Abnormality of the nervous system (1 variants)
  • Movement disorder (1 variants)
  • Rare genetic intellectual disability (1 variants)
  • Lissencephaly due to LIS1 mutation (1 variants)
  • Dandy-Walker syndrome (1 variants)
  • Congenital bilateral perisylvian syndrome (1 variants)
  • Continuous spike and waves during slow sleep;Tubulinopathy-associated dysgyria;Early myoclonic encephalopathy (1 variants)
  • Lissencephaly due to TUBA1A mutation;Corpus callosum, agenesis of;Genetic syndrome with a Dandy-Walker malformation as major feature (1 variants)
  • Autosomal recessive limb-girdle muscular dystrophy type 2D (1 variants)
  • Seizure;Global developmental delay;Decreased head circumference (1 variants)
  • Congenital fibrosis of extraocular muscles (1 variants)
  • Tubulinopathy-associated dysgyria;West syndrome (1 variants)
  • Lissencephaly;Cryptorchidism;Corpus callosum, agenesis of (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TUBA1A gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
37
clinvar
9
clinvar
46
missense
54
clinvar
97
clinvar
45
clinvar
1
clinvar
197
nonsense
0
start loss
0
frameshift
1
clinvar
1
clinvar
2
clinvar
4
inframe indel
1
clinvar
2
clinvar
2
clinvar
5
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
1
3
4
non coding
6
clinvar
1
clinvar
15
clinvar
4
clinvar
26
Total 56 106 51 53 13

Variants in TUBA1A

This is a list of pathogenic ClinVar variants found in the TUBA1A region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
12-49184799-T-C Likely benign (Jun 14, 2018)309110
12-49185008-CT-C not specified Likely benign (Nov 19, 2019)422892
12-49185019-C-T Likely benign (Jan 19, 2024)1561411
12-49185024-CT-C Tubulinopathy Likely pathogenic (Jul 01, 2018)625473
12-49185037-C-T Benign (Oct 20, 2018)793449
12-49185059-C-T Tubulinopathy • TUBA1A-associated tubulinopathy Pathogenic/Likely pathogenic (Jul 29, 2021)625512
12-49185060-C-G Tubulinopathy Pathogenic (Jul 01, 2018)625497
12-49185062-A-G Lissencephaly due to TUBA1A mutation • Tubulinopathy Likely pathogenic (Jul 01, 2018)437120
12-49185062-ACCT-A not specified • Polymicrogyria;Lissencephaly • Inborn genetic diseases Uncertain significance (Apr 09, 2021)437119
12-49185063-CCTCCTCATAATCCTT-C Lissencephaly due to TUBA1A mutation Pathogenic (Sep 26, 2019)1065497
12-49185075-C-T Uncertain significance (Jul 01, 2018)623807
12-49185081-C-G Tubulinopathy Pathogenic (Jul 01, 2018)625488
12-49185083-A-T Uncertain significance (Feb 06, 2022)2094235
12-49185090-C-T Uncertain significance (May 12, 2022)1993680
12-49185092-A-T Lissencephaly due to TUBA1A mutation • Tubulinopathy Pathogenic/Likely pathogenic (Jul 01, 2018)160148
12-49185098-T-C Lissencephaly due to TUBA1A mutation Likely pathogenic (Mar 23, 2023)2498154
12-49185100-A-C Benign (Dec 02, 2023)1290545
12-49185101-C-T Lissencephaly due to TUBA1A mutation • Tubulinopathy • Lissencephaly Pathogenic (Jun 03, 2022)7077
12-49185102-G-A Lissencephaly due to TUBA1A mutation • Inborn genetic diseases • Tubulinopathy Pathogenic (Jul 13, 2021)7076
12-49185102-G-T Tubulinopathy-associated dysgyria Pathogenic (Nov 01, 2021)1330377
12-49185103-G-A Likely benign (Dec 02, 2021)1575084
12-49185105-C-T Lissencephaly due to TUBA1A mutation Likely pathogenic (May 28, 2019)802856
12-49185109-T-C not specified Likely benign (Mar 10, 2016)384472
12-49185110-G-A Lissencephaly due to TUBA1A mutation • Tubulinopathy Pathogenic/Likely pathogenic (Jul 22, 2022)7074
12-49185118-A-G not specified Conflicting classifications of pathogenicity (Oct 01, 2023)212489

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TUBA1Aprotein_codingprotein_codingENST00000301071 44529
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9670.0334125720011257210.00000398
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense5.5872610.02680.00001552964
Missense in Polyphen1119.150.00839281437
Synonymous-0.77510494.41.100.00000507898
Loss of Function3.34115.00.06698.32e-7178

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000008790.00000879
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Tubulin is the major constituent of microtubules. It binds two moles of GTP, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha chain.;
Disease
DISEASE: Lissencephaly 3 (LIS3) [MIM:611603]: A classic type lissencephaly associated with psychomotor retardation and seizures. Features include agyria or pachygyria or laminar heterotopia, severe mental retardation, motor delay, variable presence of seizures, and abnormalities of corpus callosum, hippocampus, cerebellar vermis and brainstem. {ECO:0000269|PubMed:17584854, ECO:0000269|PubMed:25818041}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Tight junction - Homo sapiens (human);Phagosome - Homo sapiens (human);Gap junction - Homo sapiens (human);Pathogenic Escherichia coli infection - Homo sapiens (human);Apoptosis - Homo sapiens (human);miR-targeted genes in epithelium - TarBase;miR-targeted genes in leukocytes - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in squamous cell - TarBase;Pathogenic Escherichia coli infection;Parkin-Ubiquitin Proteasomal System pathway;stathmin and breast cancer resistance to antimicrotubule agents;downregulated of mta-3 in er-negative breast tumors;Post-translational protein modification;Metabolism of proteins;Chaperonin-mediated protein folding;TCR;Formation of tubulin folding intermediates by CCT/TriC;p73 transcription factor network;Carboxyterminal post-translational modifications of tubulin;Regulation of PLK1 Activity at G2/M Transition;Recruitment of mitotic centrosome proteins and complexes;Loss of Nlp from mitotic centrosomes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;AURKA Activation by TPX2;G2/M Transition;Mitotic G2-G2/M phases;Protein folding;Recruitment of NuMA to mitotic centrosomes;Mitotic Prometaphase;M Phase;Cell Cycle;Prefoldin mediated transfer of substrate to CCT/TriC;Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding;Post-chaperonin tubulin folding pathway;Cell Cycle, Mitotic;Anchoring of the basal body to the plasma membrane;Cilium Assembly;Organelle biogenesis and maintenance (Consensus)

Intolerance Scores

loftool
0.278
rvis_EVS
-0.25
rvis_percentile_EVS
35.42

Haploinsufficiency Scores

pHI
0.926
hipred
Y
hipred_score
0.771
ghis
0.506

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.681

Mouse Genome Informatics

Gene name
Tuba1a
Phenotype
growth/size/body region phenotype; cellular phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);

Zebrafish Information Network

Gene name
tuba1a
Affected structure
whole organism
Phenotype tag
abnormal
Phenotype quality
dead

Gene ontology

Biological process
G2/M transition of mitotic cell cycle;microtubule cytoskeleton organization;mitotic cell cycle;microtubule-based process;regulation of G2/M transition of mitotic cell cycle;cytoskeleton-dependent intracellular transport;regulation of synapse organization;cell division;ciliary basal body-plasma membrane docking
Cellular component
nucleus;cytoplasm;cytosol;microtubule;cytoplasmic microtubule;microtubule cytoskeleton;neuromuscular junction;cytoplasmic ribonucleoprotein granule;myelin sheath;membrane raft;recycling endosome;extracellular exosome
Molecular function
GTPase activity;structural molecule activity;structural constituent of cytoskeleton;protein binding;GTP binding;protein domain specific binding